As of Nov 24
| 0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for Aeolus Pharmaceuticals Inc have a median target of 1.25, with a high estimate of 1.25 and a low estimate of 1.25. The median estimate represents a +400.20% increase from the last price of 0.25.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.